UK tribunal backs CMA in “extremely serious” excessive pricing case
Shutterstock/luchschenF
The UK’s antitrust authority rightly fined Auden McKenzie and Actavis UK for inflating the price of hydrocortisone by over 10,000% but was wrong to sanction another company as part of its decision, the Competition Appeal Tribunal has ruled.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now